Skip to main content

Policies & Regulations

FDA releases guidance regarding civil money penalties

The Food and Drug Administration (FDA) has issued the final guidance titled “Civil Money Penalties Relating to the ClinicalTrials.gov Data Bank.” This guidance describes the authority of the FDA to assess civil money...

NIH Single IRB Policy for Multi-site Research

For applications with due dates on or after January 25, 2018, NIH expects that all sites participating in multi-site studies, which involve non-exempt human subjects research funded by the NIH, will use a single...

UNC Code and Standard of Research Conduct Policies

On June 8, 2017, Vice Chancellor for Research Terry Magnuson officially approved UNC's Research Code of Conduct. With his signature, UNC formalized the high standards that it expects from members of the research...

UNC IRB clarifies promotion guidelines for study listings

New UNC SOP guidelines effective June 2, 2017 require a change to the Join the Conquest study listing form approval for the compensation section only. Per UNC IRB SOP 2.4.10.1 "… In keeping with the DHHS and FDA...

New requirements for publication of a clinical trial report

The International Committee of Medical Journal Editors will soon require data sharing statements as a consideration for publication of a clinical trial report. The International Committee of Medical Journal Editors...

NIH definition of a Clinical Trial

The NIH definition of a clinical trial is very broad. Some investigators conducting human subjects research may not be aware that NIH considers their study to be a clinical trial. Correctly identifying whether a study is...